Form 4 for BSX Boston Scientific
Accepted 2023-03-31 00:00:00 ET · period of report 2023-03-31 · accession 0001225208-23-004333 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-03-31 | 2023-03-31 | BSX | Monson Jonathan | SVP, CAO, Gbl Ctrl | M - OptEx | $12.89 | +5,000 | 39.9K | +14% | +$64.5K |
| D | 2023-03-31 | 2023-03-31 | BSX | Monson Jonathan | SVP, CAO, Gbl Ctrl | S - Sale+OE | $50.00 | -5,000 | 34.9K | -13% | -$250.0K |
| D | 2023-03-31 | 2023-03-31 | BSX | Monson Jonathan | SVP, CAO, Gbl Ctrl | M - OptEx | $0.00 | -5,000 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-03-31 | M | A | 5,000 | $12.89 | 39,868 | D | — | — | |
| 2 | Common | Common Stock | 2023-03-31 | S | D | 5,000 | $50.00 | 34,868 | D | — | — | |
| 3 | Derivative | Stock Option (Right to Buy) | 2023-03-31 | M | D | 5,000 | $0.00 | 0 | D | $12.89 · — to 2024-12-01 | 5,000 Common Stock | (F2) Grant to the reporting person on December 1, 2014, of an option to purchase 17,901 shares of common stock. |